Eventide Healthcare & Life Sciences I (ETIHX)

Nasdaq • Currently down 0.75 (-1.36%) in today's trading session

1 member of Congress has disclosed 1 trade in Eventide Healthcare & Life Sciences I (ETIHX) via STOCK Act filings. The most recent disclosure was a sale by Gary Palmer on 16 June 2023. Aggregate disclosed activity totals roughly $8K in sales (midpoint estimates from bracketed disclosure amounts).

Eventide Healthcare & Life Sciences I is currently trading at $55.07, positioned at 65% of its 52-week range ($41.18 – $62.42).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$55.07
24h Change
-0.75 (-1.36%)
52 Week Range
$41.18–$62.42
View on NASDAQ

Eventide Healthcare & Life Sciences I Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for ETIHX

Select to highlight on chart
1 transactions
Compliance: 0%
Gary Palmer16 Jun 20237 May 2024SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$1.76B

Volume

0

Beta

1.01

P/E Ratio

-

Fundamentals

EPS

-

Div. Yield

-

Open

$54.49

Day Range

$54.49 – $55.07

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
NASDAQ · USD
Country
US
IPO Date
2012-12-27
Website
www.morganstanley.com/im/en-us/individual-investor/products/mutual-funds/eaton-vance-tax-advantaged-global-dividend-opportunities-fund-eti.html

Under normal market conditions, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, option...

No earnings data available for this stock.

Dividends

Dividend History

16 Dec 2021
Amount $0.7390
17 Dec 2020
Amount $1.9370
17 Dec 2019
Amount $0.8700
18 Dec 2018
Amount $1.9760
19 Dec 2017
Amount $0.3710
22 Dec 2015
Amount $0.2930

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about ETIHX

Which members of Congress have traded ETIHX?
1 member of Congress has disclosed 1 trade in Eventide Healthcare & Life Sciences I (ETIHX) under the STOCK Act: Gary Palmer.
When was ETIHX most recently disclosed by Congress?
The most recent ETIHX disclosure was a sale by Gary Palmer on 16 June 2023.
What is the total disclosed congressional trading volume for ETIHX?
Members of Congress have disclosed approximately $8K in ETIHX sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in ETIHX?
This ETIHX page updates as soon as new STOCK Act disclosures are filed for Eventide Healthcare & Life Sciences I. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.